in animal trials the drug has shown activity against cytomegalovirus, adenoviruses, bk virus, smallpox, and herpes simplex viruses. preliminary "in vitro" tests have also shown it to have potential for the treatment of ebola virus disease, which is somewhat paradoxical, as ebola is not a dna virus.